Inhibition of P38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.110.209205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

Chronic P38 Mitogen-Activated Protein Kinase Inhibition Improves Vascular Function and Remodeling in Angiotensin II-dependent Hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2016English

P38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage

Hypertension
Internal Medicine
2007English

P38 Mitogen-Activated Protein Kinase Regulates IL‐8 Expression in Human Pulmonary Vascular Endothelial Cells

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis

PLoS ONE
Multidisciplinary
2016English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14); X-Box Binding Protein 1 (XBP1)

Science-Business eXchange
2011English

Cutaneous P38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

P38 MAP Kinase Inhibition Reduces Propionibacterium Acnes-Induced Inflammation in Vitro

Dermatology and Therapy
Dermatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy